azathioprine

Drug rediscovery in gastroenterology: from off-label to on-label use of thioguanine in inflammatory bowel disease
Nanne K H de Boer, Melek Simsek, Berrie Meijer, Markus F Neurath, Ad van Bodegraven, Chris J J Mulder

Gut Oct 2023, 72 (10) 1985-1991; DOI: 10.1136/gutjnl-2023-329679
Risk of acute arterial events associated with treatment of inflammatory bowel diseases: a nationwide Danish cohort study
Daniel Ward, Mikael Andersson, Nynne Nyboe Andersen, Kristine Højgaard Allin, Laurent Beaugerie, Tine Jess, Julien Kirchgesner

Gut Nov 2022, 71 (11) 2373-2374; DOI: 10.1136/gutjnl-2021-326462
There is still a place for optimised thiopurine therapy in IBD
Femke Crouwel, Hans J C Buiter, Nanne K H de Boer

Gut Nov 2021, 70 (11) 2207; DOI: 10.1136/gutjnl-2020-323481
COVID-19 and IBD drugs: should we change anything at the moment?
Charlie W Lees, Peter M Irving, Laurent Beaugerie

Gut Apr 2021, 70 (4) 632-634; DOI: 10.1136/gutjnl-2020-323247
Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn’s disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource
Evangelos Stournaras, Wendi Qian, Apostolos Pappas, You Yi Hong, Rasha Shawky, UK IBD BioResource Investigators, Tim Raine, Miles Parkes

Gut Apr 2021, 70 (4) 677-686; DOI: 10.1136/gutjnl-2019-320185
Anti-TNF-associated immunogenicity: use a retroactive drug but a proactive approach
Ashish Srinivasan, Peter De Cruz, Daniel R van Langenberg

Gut Apr 2021, 70 (4) 812-813; DOI: 10.1136/gutjnl-2020-322302
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, IBD guidelines eDelphi consensus group, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen, A Barney Hawthorne

Gut Dec 2019, 68 (Suppl 3) s1-s106; DOI: 10.1136/gutjnl-2019-318484
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low
R J Farrell, Y Ang, P Kileen, D S O'Briain, D Kelleher, P W N Keeling, D G Weir

Gut Oct 2000, 47 (4) 514-519; DOI: 10.1136/gut.47.4.514
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide
P W Lowry, C L Franklin, A L Weaver, C L Szumlanski, D C Mays, E V Loftus, W J Tremaine, J J Lipsky, R M Weinshilboum, W J Sandborn

Gut Nov 2001, 49 (5) 656-664; DOI: 10.1136/gut.49.5.656
Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease
P W Lowry, C L Franklin, A L Weaver, M Gennett Pike, D C Mays, W J Tremaine, J J Lipsky, W J Sandborn

Gut Nov 2001, 49 (5) 665-670; DOI: 10.1136/gut.49.5.665

Main menu

azathioprine

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

azathioprine

Pages